drugset / Trial / NCT00004400

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

NCT00004400

Phase 2 Completed 56 enrolled Charles Drew University of Medicine and Science
RandomizedDouble-blindTreatment

Summary

OBJECTIVES: I. Determine whether physiologic testosterone replacement can increase fat-free mass, therefore contributing to weight maintenance, improved muscle function, and quality of life in HIV-infected women. II. Examine the mechanism of testosterone-induced increase in fat-free mass.

Timeline

Start
1997-04
Primary completion
Completion
2001-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule Other

Indications